2024 Fall FPAN Institute: GLP-1 Medications
On November 1, 2024, FPAN hosted an educational event focused on Glucagon-Like Peptide-1 Receptor Agonists (GLP-1s). The informative session covered best practices and the impact of GLP-1s on population health, and it provided an opportunity for networking. The well attended event offered both in-person and online accommodations.
The half-day event offered included a value-based care update, a GLP-1 overview, and a panel discussion of the impact of GLP-1s on population health. The speakers included:
- John Kvasnicka, MD, FPAN President
- Gina Morgan, FPAN Executive Director
- Allyson Schlichte, PharmD, MBA, Fairview Manager of Ambulatory Programs
- Hannah Lichtsinn, MD, FPAN Medical Officer of Network and Credentialing
- Amanda Brummel, PharmD, Fairview VP of Clinical Pharmacy Services
- Lori Skinner, DNP, RN, Medica Value-Based Care Director
- Allison Rodriguez, PA-C, Associates in Women’s Health
Gina Morgan, FPAN Executive Director said, “The FPAN educational session on GLP-1s was a success, bringing together healthcare professionals for an engaging and informative discussion on the transformative impact of GLP-1s on population health. Attendees left with valuable insights and information to better serve their patients and practices.”
FPAN looks forward to hosting more educational opportunities in the future to bring value to the network and support high quality patient care.
